lockScience & Innovation / InfographicCell and gene key focus areas
At Novartis, we are reimagining medicine to produce breakthroughs and address major unmet needs for patients with devastating diseases, including genetic disorders and certain deadly cancers. These efforts are done in collaboration with scientists, physicians, academia, industry partners, and patients.
lockScience & Innovation / InfographicA new era of medicine
Cell and gene therapies could help reduce or eliminate the need for treatments that need to be taken continuously, often for life
lockDisease Awareness / InfographicThe Sickle Cell World Assessment Survey (SWAY) results
The Sickle Cell World Assessment Survey (SWAY) uncovers the impact this disease has on patients and their families.
lockDisease Awareness / InfographicCancer 2030: A growing global crisis
Cancer 2030: A growing global crisis. This infographic shows the projected cancer cases by region.
ImagelockMalaria Initiative / ImageYoung Malaria Patient
A young malaria patient being given a dose of pediatric antimalarial medicine at the AMREF Clinic in the Kibera area of Nairobi, Kenya.
ImagelockManufacturing / ImageWorldwide Distribution Center for the Novartis Antimalarial in Basel, Switzerland
Worldwide distribution center for the Novartis antimalarial in Basel, Switzerland: an employee checks a shipment headed for Mozambique for the US Presidential Malaria Initiative.
ImagelockLocations / ImageView of the Fabrikstrasse, Novartis HQ
ImagelockScience & Innovation / ImageT-Cell arrival at the Novartis manufacturing facility
A cancer patient's frozen T-Cells arrive at a Novartis facility to be reengineered.
ImagelockNovartis Social Business / ImageSMS for Life Training Session
SMS for Life training session teaching healthcare workers how to use text messaging to monitor stock levels of life-saving antimalarials. In Kenya, Machacos district, SMS for Life also includes patient surveillance data on the testing of malaria patients and the use of artemisinin-based combination therapies (ACTs).
ImagelockNovartis Social Business / ImageSMS for Life
SMS for Life is an innovative public-private partnership led by Novartis under the umbrella of the Roll Back Malaria Partnership. The program has been rolled out across Tanzania and pilots are taking place in Ghana and Kenya.
ImagelockScience & Innovation / ImagePatient's frozen T-Cells
The Frozen T-Cells of a cancer patient.
ImagelockScience & Innovation / ImageMode of Action of a CGRP Receptor Blocker
Mode of Action of a CGRP Receptor Blocker, calcitonin gene-related peptide (CGRP), CGRP receptor complex, CGRP receptor blocker targeting the receptor complex.